Expert Discusses Changes in Diabetes Care | APhA 2025
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, discusses recent advancements in diabetes care.
Potential Challenges in Using ChatGPT for Pharmacy Services
With the rise of large-language models like ChatGPT, pharmacists must know the potential challenges they may encounter when using these new technologies.
How Pharmacists Can Support Adherence Among Patients Using GLP-1s
Lydia Newsom, PharmD, discusses how to support patients who are struggling with injection techniques or gastrointestinal side effects of GLP-1s.
Pharmacy Owner Highlights Experiences With Misinformation During COVID-19 Pandemic
In the evolving landscape of community pharmacy, the Prescription Shoppe emerged as a beacon of resilience and patient-centered care during the COVID-19 pandemic.
Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025
Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.
Q&A: How Pharmacists Can Make a Difference Beyond the Counter
Jade Ranger, co-owner and pharmacist of the Prescription Shoppe, discusses how her pharmacy put patients first during the COVID-19 pandemic.
Addressing Burnout in Pharmacy | APhA 2025
Alisha Reed, PharmD, founder of Your Self Care Prescription, LLC, discussed how pharmacists can implement wellness programs to reduce burnout.
FDA Approves Vutrisiran For Adult Patients With ATTR-CM
The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.
How Pharmacists Can Implement Injectable Contraception Programs
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses tips for implementing pharmacist-administered injectable contraception programs.
What Pharmacists Should Know About Psychedelic Medicine | APhA 2025
Mark Garofoli, PharmD, BCGP, CPE, director of experiential learning at West Virginia University, discusses the potential of psuychedelic therapy in pharmacy.
Pharmacists Play Critical Role in Monitoring Controlled Substances | APhA 2025
Emily Leppien, PharmD, BCPS, BCPP, clinical associate professor of pharmacy practice at Binghamton University, discusses identifying potential red flags for substance use disorder.
Medications, Devices Available for Optimal Cardiovascular Health | APhA 2025
Heather Johnson, PharmD, BCACP, CTTS, and Heather Roth, BSPharm, RPh, discuss medications and devices used for improving cardiovascular health among patients with or without diabetes.
Pharmacists Play Crucial Role in Counseling, Reporting Adverse Drug Events
National Adverse Drug Event Awareness Day occurs annually on March 24 to raise awareness about minimizing the risk of adverse events caused by medications.
Expert Discusses Topical Analgesics as First-Line Treatment of Pain | APhA 2025
Jeffrey Gudin, MD, faculty in the department of anesthesiology and pain management at the University of Miami, said topical analgesics are safer alternatives to systemic medications.
Introducing Clinical Services in Pharmacy Addresses Patient Needs | APhA 2025
Darcy Aslett, PharmD, residency program director for PGY-1 community-based residency at St. Luke's Health System, discusses clinical services in pharmacies for underserved patients.
CGM User, Device Errors Pharmacists Should Understand | APhA 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses the various errors patients experience when using CGM devices.
The Power of Pharmacists to Educate, Counsel on OTC Product Use | APhA 2025
Stefanie Ferreri, PharmD, BCACP, FAPhA, discusses literature exploring OTC drugs, supplements, and devices used for non-prescription or self-care purposes.
Expert Discusses Challenges and Ethical Considerations of AI | APhA 2025
Ravi Patel, PharmD, MBA, MS, lead innovation advisor in the School of Pharmacy at the University of Pittsburgh, discusses challenges with new technology and the future of artificial intelligence in pharmacy.
Diabetes Care in Clinical, Community Pharmacy Practices | APhA 2025
Heather Johnson, PharmD, BCACP, CTTS, and Heather Roth, BSPharm, RPh, compare patients’ diabetes outcomes in clinical and community pharmacy settings.
Pharmacists Play Critical Role in Optimizing Anticoagulation Therapy for Older Adults | APhA 2025
Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses the safety and efficacy of anticoagulation for this population.
The Importance of Staying Informed on New OTC Product Releases, Recalls | APhA 2025
Dan Krinsky, BS, MS, RPh, FAPhA, and Stefanie Ferreri, PharmD, BCACP, FAPhA, discuss new OTC product releases, recalls, and other updates pharmacists should be aware of.
Artificial Intelligence in Pharmacy Has Potential to Change Landscape | APhA 2025
Ravi Patel, PharmD, MBA, MS, lead innovation advisor in the School of Pharmacy at the University of Pittsburgh, explains how artificial intelligence can be used in pharmacy.
Why Pharmacists Should Never Rely Solely on AI's OTC Recommendations | APhA 2025
Dan Krinsky, BS, MS, RPh, FAPhA, discusses the use of ChatGPT and artificial intelligence in assisting pharmacists for the management of OTC self-care products.
OTC Analgesic Toxicity Common Among Children
According to poison control data, many children aged 0 to 17 experience toxicity from over-the-counter analgesics like ibuprofen and acetaminophen.
Expert Discusses Navigating Anticoagulation in Older Adults | APhA 2025
Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses initiating anticoagulation for older adults as well as the risk-benefit balance of the therapy.
Effective Communication Can Bridge Gaps in Care | APhA 2025
Sally Arif, PharmD, professor in the College of Pharmacy at Midwestern University, discusses how pharmacists can effectively communicate with diverse patients.
Pharmacists’ Expertise in Contraceptive Counseling Amid Ongoing Challenges | APhA 2025
Jasmine Cutler, PharmD, discusses the unique expertise pharmacists possess in order to counsel patients seeking any type of contraceptive product.
Q&A: Pharmacists’ Role in GLP-1 Diet, Exercise Counseling
Lydia Newsom, PharmD, discuses how pharmacists can support patients using GLP-1s.
Stopping SSRIs, SNRIs During Pregnancy Not Linked to Adverse Psychiatric Outcomes
Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.
Q&A: Community Pharmacists Well-Positioned to Provide Injectable Contraception
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.